203 related articles for article (PubMed ID: 1384536)
21. Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship.
Holmes CH; Simpson KL
Baillieres Clin Obstet Gynaecol; 1992 Sep; 6(3):439-60. PubMed ID: 1446417
[TBL] [Abstract][Full Text] [Related]
22. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
23. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
Cosio FG; Shibata T; Rovin BH; Birmingham DJ
Kidney Int; 1994 Oct; 46(4):986-92. PubMed ID: 7532249
[TBL] [Abstract][Full Text] [Related]
24. Localization of the complement regulatory proteins in the normal human kidney.
Ichida S; Yuzawa Y; Okada H; Yoshioka K; Matsuo S
Kidney Int; 1994 Jul; 46(1):89-96. PubMed ID: 7523758
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line.
Bjørge L; Jensen TS; Matre R
Cancer Immunol Immunother; 1996 Mar; 42(3):185-92. PubMed ID: 8640847
[TBL] [Abstract][Full Text] [Related]
26. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
[TBL] [Abstract][Full Text] [Related]
27. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
Seya T; Hara T; Matsumoto M; Sugita Y; Akedo H
J Exp Med; 1990 Dec; 172(6):1673-80. PubMed ID: 2258699
[TBL] [Abstract][Full Text] [Related]
28. Complement alternative pathway activation and control on membranes of human lymphoid B cell lines.
Caudwell V; Porteu F; Calender A; Pangburn MK; Halbwachs-Mecarelli L
Eur J Immunol; 1990 Dec; 20(12):2643-50. PubMed ID: 1702720
[TBL] [Abstract][Full Text] [Related]
29. Decay-accelerating factor protects human trophoblast from complement-mediated attack.
Cunningham DS; Tichenor JR
Clin Immunol Immunopathol; 1995 Feb; 74(2):156-61. PubMed ID: 7530176
[TBL] [Abstract][Full Text] [Related]
30. Decay-accelerating factor and membrane cofactor protein.
Lublin DM; Atkinson JP
Curr Top Microbiol Immunol; 1990; 153():123-45. PubMed ID: 1688754
[No Abstract] [Full Text] [Related]
31. Complement regulation.
Meri S; Jarva H
Vox Sang; 1998; 74 Suppl 2():291-302. PubMed ID: 9704459
[TBL] [Abstract][Full Text] [Related]
32. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
[No Abstract] [Full Text] [Related]
34. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
[TBL] [Abstract][Full Text] [Related]
35. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
36. Structure and function of decay accelerating factor CD55.
Nicholson-Weller A; Wang CE
J Lab Clin Med; 1994 Apr; 123(4):485-91. PubMed ID: 7511675
[TBL] [Abstract][Full Text] [Related]
37. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
38. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
[TBL] [Abstract][Full Text] [Related]
39. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
[TBL] [Abstract][Full Text] [Related]
40. Membrane defence against complement lysis: the structure and biological properties of CD59.
Davies A; Lachmann PJ
Immunol Res; 1993; 12(3):258-75. PubMed ID: 7507156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
